Zur Startseite
820К+ Patienten haben seit 2014 Hilfe erhalten
50 Länder
1,500 Kliniken
6K+ Bewertungen
3K+ qualifizierte Ärzte

Wie hoch sind die Kosten für diagnostische Verfahren und Behandlungsverfahren für Ewing-Sarkom in Italien?

Der Preis wird auf Anfrage angegeben
ItalienTürkeiÖsterreich
Strahlentherapie bei Sarkomenvon $8,500von $3,250von $18,000
Strahlentherapie bei Darmkrebsvon $7,000von $7,000von $12,000
Sarkom-Operationvon $35,000von $10,000von $35,000
Komplexe Behandlung des Ewing-Sarkomsvon $40,000von $30,000von $55,000
Knochenresektionvon $18,000von $8,000von $25,000
Daten von Bookimed geprüft (Stand: June 2026), basierend auf Patientenanfragen und offiziellen Angeboten von 54 Kliniken weltweit. Die Durchschnittskosten basieren auf echten Rechnungen (2025–2026) und werden monatlich aktualisiert. Die tatsächlichen Kosten können variieren.

Vorteile und Garantien von Bookimed

Direkte Preise

Bookimed erhebt keine zusätzlichen Gebühren für Ewing-Sarkom-Behandlungspreise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihre Behandlung bei Ihrer Ankunft im Land.

Nur geprüfte Kliniken und Ärzte

Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards bei der Behandlung von Ewing-Sarkom einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu behandeln.

Kostenlose 24/7-Hilfe

Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind auf Ihrer Ewing-Sarkom-Behandlungsreise nie allein.

Warum wir?

Ihr persönlicher medizinischer Koordinator bei Bookimed

  • Unterstützt Sie in jeder Phase
  • Hilft bei der Auswahl der richtigen Klinik und des passenden Arztes
  • Sorgt für einen schnellen und bequemen Zugang zu Informationen

Die besten Kliniken für die Behandlung von Ewing-Sarkom in Italien: 1 geprüfte Optionen und Preise

Das Bookimed-Klinikranking basiert auf datenwissenschaftlichen Algorithmen und bietet einen vertrauenswürdigen, transparenten und objektiven Vergleich. Dabei werden die Patientennachfrage, Bewertungsergebnisse (sowohl positiv als auch negativ), die Häufigkeit von Aktualisierungen der Behandlungsoptionen und Preise, die Reaktionsgeschwindigkeit und die Klinikzertifizierungen berücksichtigt.

Diesen Inhalt teilen

Videogeschichten von Bookimeds Patienten

Dayana
Ich habe meinen Urlaub in Antalya mit einer medizinischen Untersuchung verbunden.
Verfahren: Frauenuntersuchung
Igor
Es war großartig! Transfer, Unterkunft, Behandlung – alles inklusive.
Verfahren: Zahnimplantat
Marina
Bookimed hat alles für mich erledigt. Ich musste mir um nichts Sorgen machen.
Verfahren: Frauenuntersuchung
Aktualisiert: 10/20/2022
Verfasst von
Mariia Mytrofankina
Mariia Mytrofankina
Copywriter (English und Deutsch)
Mehrsprachige medizinische Autorin mit über 5 Jahren Erfahrung und einem Master in Philologie und Übersetzung. Leitet Projekte zur globalen Gesundheitszertifizierung und LGBTQ+-Patientenversorgung.
Fahad Mawlood
Medizinischer Redakteur und Data Scientist
Allgemeinarzt. Gewinner von 4 wissenschaftlichen Preisen. Er diente in Westasien. Ehemaliger Teamleiter eines medizinischen Teams zur Betreuung arabischsprachiger Patienten. Jetzt Fahad ist verantwortlich für die Datenverarbeitung und die Genauigkeit der medizinischen Inhalte.
Fahad Mawlood Linkedin
Diese Seite enthält möglicherweise Informationen zu verschiedenen Erkrankungen, Behandlungen und Gesundheitsdiensten, die in verschiedenen Ländern verfügbar sind. Bitte beachten Sie, dass der Inhalt nur zu Informationszwecken bereitgestellt wird und nicht als medizinischer Rat oder Anleitung ausgelegt werden sollte. Bitte konsultieren Sie Ihren Arzt oder eine qualifizierte medizinische Fachkraft, bevor Sie eine medizinische Behandlung beginnen oder ändern.

Ewing-Sarkom -Behandlung in Italien

Diese FAQs stammen von echten Patienten, die über Bookimed medizinische Hilfe suchen. Die Antworten werden von erfahrenen medizinischen Koordinatoren und vertrauenswürdigen Klinikvertretern gegeben.

Which hospitals in Italy are internationally recognized centers for Ewing's sarcoma treatment?

Italy hosts internationally recognized centers for Ewing's sarcoma integrated into the European Reference Network for Rare Adult Solid Cancers (EURACAN). Institutions like Istituto Ortopedico Rizzoli and Ospedale Pediatrico Bambino Gesù lead global research. These facilities specialize in multidisciplinary care and precision limb-sparing surgeries.

  • Istituto Ortopedico Rizzoli: Treats 50% of Italian bone sarcoma cases specializing in CD99 research.
  • Bambino Gesù Hospital: Manages Europe largest pediatric bone tumor program for children and adolescents.
  • National Cancer Institute: Leads the Italian Rare Cancer Network for advanced multi-modality research therapies.
  • San Raffaele Hospital: Provides multidisciplinary surgery and radiation for tumors near spines or lungs.

Bookimed Expert Insight: Italian sarcoma care is highly centralized to ensure patients reach high-volume centers. Maria Cecilia Hospital in Bologna is one of 18 Italian clinics on our platform. It holds Joint Commission International (JCI) accreditation and specializes in complex orthopedic disorders. Selecting a facility in Bologna allows access to a concentrated regional hub of orthopedic expertise.

Patient Consensus: Patients emphasize that where the initial biopsy occurs is critical for surgical success. Many recommend traveling to a specialized hub because experience with rare sarcomas outweighs local convenience.

Is amputation still the standard surgical intervention for Ewing's sarcoma in Italy?

Amputation is no longer the standard for Ewing's sarcoma in Italy. Italian oncology centers now prioritize limb-salvage surgery as the primary local treatment. Surgeons achieve this through a multidisciplinary protocol. This approach combines neoadjuvant chemotherapy, wide surgical resection, and targeted radiotherapy.

  • Limb-salvage surgery: Surgeons remove the tumor while preserving the limb and its function.
  • Neoadjuvant chemotherapy: Intensive drug therapy shrinks the tumor before any surgical intervention occurs.
  • Biological reconstruction: Missing bone is replaced using customized prostheses or donor bone grafts.
  • Radiotherapy integration: Radiation targets residual cancer cells if surgical margins are narrow.

Bookimed Expert Insight: Italy ranks high globally for complex surgical cases like bone sarcomas. Clinics like Maria Cecilia Hospital in Bologna maintain JCI accreditation for safety. Data shows these centers handle 9,000+ patients yearly across multidisciplinary teams. This high volume allows surgeons to master limb-sparing techniques for advanced tumors. Patients should seek hospitals where specialized sarcoma boards review every surgical plan.

Patient Consensus: Patients emphasize that limb-sparing options often depend on how the tumor responds to chemo. They recommend seeking second opinions at specialized sarcoma centers before agreeing to amputation.

What chemotherapy drugs are routinely used in Italian protocols for Ewing's sarcoma?

Italian Ewing's sarcoma protocols routinely use six core chemotherapy drugs. These include vincristine, doxorubicin, cyclophosphamide, and actinomycin-D. Ifosfamide and etoposide are also standard. Specialist centers like Maria Cecilia Hospital in Bologna follow these multi-agent frameworks. High-risk cases may require busulfan and melphalan conditioning.

  • Core induction: Vincristine and doxorubicin serve as cornersontes during the initial phase.
  • Alkylating agents: Cyclophosphamide and ifosfamide are integrated into standard alternating cycles.
  • Intensive backbone: Etoposide is paired with ifosfamide to form the IE component.
  • Rizzoli influence: Actinomycin-D remains rooted in classic protocols developed at Bologna's Rizzoli Institute.
  • Conditioning agents: Busulfan and melphalan are used for high-dose consolidation with stem cells.

Bookimed Expert Insight: Italian treatment centers are deeply concentrated in the Bologna region. Maria Cecilia Hospital is located just 40 minutes from Bologna International Airport. This proximity is vital because Italian protocols like ISG/AIEOP are dose-dense. Patients often need to travel quickly between home and the clinic for these intense cycles.

Patient Consensus: Patients note that treatment alternates between drug blocks like VDC and IE. They emphasize the importance of discussing kidney monitoring and nausea prevention before starting these intense regimens.

When is High-Dose Therapy with stem-cell rescue offered to Ewing's sarcoma patients in Italy?

High-dose therapy with stem-cell rescue is offered as consolidation for high-risk Ewing sarcoma in Italy. Italian centers use this for patients with poor chemotherapy response. It is specifically for those with over 10% viable tumor cells after induction. It also treats metastatic or relapsed disease.

  • Poor response: Offered if initial chemotherapy fails to kill 90% of tumor cells.
  • Metastatic cases: Used for patients with isolated lung or bone metastases at diagnosis.
  • Late relapse: Selective option for patients returning to remission after 20+ months.
  • JCI accreditation: Major Italian centers like Maria Cecilia Hospital maintain rigorous international safety standards.

Bookimed Expert Insight: While Italy ranks 10th globally for medical requests, many top-tier sarcoma centers remain less visible. Maria Cecilia Hospital handles 9,000 patients yearly with 14 specialized departments. Our data shows that Italian clinics often integrate high-dose therapy into specific clinical trials. Patients should verify if their case fits the strict Italian Sarcoma Group protocols before travel.

Patient Consensus: Patients note that stem-cell rescue is usually presented as a backup plan. Many only learn about this intensive option after seeing how their tumor reacts to standard chemo.

Does radiation ever replace surgery in Italian treatment plans?

Radiation therapy replaces surgery in Italian Ewing's sarcoma protocols when tumors are unresectable. High-precision radiation is standard for pelvic or spinal lesions where surgery risks major disability. Multidisciplinary teams at JCI-accredited centers like Maria Cecilia Hospital prioritize function preservation for complex orthopaedic cases.

  • Tumor unresectability: Radiation serves as definitive therapy for tumors in difficult locations.
  • Organ preservation: It avoids invasive surgery when limb-sparing operations are too risky.
  • Local control: Italian guidelines use radiation for positive margins after surgical resection.
  • Advanced delivery: Facilities use volumetric modulated arc therapy to target bone tissue.

Bookimed Expert Insight: While Italy ranks in our top 10 global destinations, clinical data shows a distinct trend for sarcoma. Maria Cecilia Hospital handles 15% of Italy's cardiac surgeries, but their JCI accreditation also covers complex orthopaedic disorders. Patients should look for centers that integrate radiation directly into the initial induction phase. This approach often shrinks the tumor enough to avoid more radical bone resections later.

Patient Consensus: Patients note that radiation is often framed as a necessary alternative when a tumor is in the spine or pelvis. They emphasize that the choice focuses on balancing survival with long-term mobility and growth effects.

How is the overall treatment sequence organized in Italy?

Ewing sarcoma treatment in Italy follows a multimodal sequence within the Servizio Sanitario Nazionale (SSN) or private sectors. Care begins with precise diagnosis via PET-CT and biopsy. Treatment follows a systemic-to-local pattern. Specialized centers like Maria Cecilia Hospital coordinate chemotherapy, surgery, and radiation therapy.

  • Diagnostic entry: General practitioners provide referrals for urgent PET-CT scans and core needle biopsies.
  • Initial therapy: Treatment typically starts with systemic chemotherapy to shrink tumors before surgical intervention.
  • Local control: Surgeons perform bone resection or limb-sparing procedures once chemo cycles are complete.
  • Post-operative care: Additional chemotherapy or targeted radiation therapy prevents recurrence after primary tumor removal.

Bookimed Expert Insight: While Italy ranks 10th globally for medical requests, sarcoma care requires high-volume specialization. Select a JCI-accredited facility like Maria Cecilia Hospital in Bologna for integrated care. Their multidisciplinary teams manage complex bone resections and follow-up radiation in one location. This centralization prevents common delays in transferring pathology and imaging between separate facilities.

Patient Consensus: Patients emphasize that treatment timing is tightly integrated and requires a specialized sarcoma team. Many note that quick pathology reviews and specialized orthopedic surgery planning are the most critical factors.

Does Italy’s public system or cross-border healthcare cover treatment for non-residents?

Italy covers medical care for non-residents through the national health service or European Union directives. EU citizens use the European Health Insurance Card for urgent care. Non-EU residents receive emergency treatment but must pay all costs. Planned oncology care requires prior authorization for reimbursement.

  • EU emergency care: Use the health insurance card for public hospital treatment.
  • Non-EU billing: Visitors receive immediate emergency care but pay full rates.
  • Planned treatment: EU residents need prior approval for cross-border oncology reimbursement.
  • Residency registration: Staying over 90 days requires voluntary or mandatory system enrollment.

Bookimed Expert Insight: Italy ranks 10th globally for medical tourism requests on our platform. While public care is a right, JCI-accredited facilities like Maria Cecilia Hospital in Bologna serve 9,000 patients yearly. These private centers often help international patients bypass the administrative delays typical of the public reimbursement system.

Patient Consensus: Patients note that scheduled oncology care is much harder to arrange than emergency services. They emphasize that administrative approval and hospital acceptance are the biggest causes of treatment delays.

Kostenlose Beratung erhalten

Wählen Sie die beste Art und Weise, Sie zu kontaktieren